Zoetis Inc (ZTS) Position Cut by CGOV Asset Management

CGOV Asset Management reduced its position in shares of Zoetis Inc (NYSE:ZTS) by 5.6% in the 4th quarter, Holdings Channel reports. The firm owned 134,355 shares of the company’s stock after selling 8,000 shares during the quarter. Zoetis makes up 0.5% of CGOV Asset Management’s portfolio, making the stock its 22nd biggest holding. CGOV Asset Management’s holdings in Zoetis were worth $12,116,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. increased its position in shares of Zoetis by 16.8% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock valued at $100,000 after acquiring an additional 230 shares during the last quarter. Steward Partners Investment Advisory LLC acquired a new stake in shares of Zoetis during the third quarter valued at about $114,000. Harfst & Associates Inc. increased its position in shares of Zoetis by 16.1% during the second quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock valued at $117,000 after acquiring an additional 260 shares during the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its position in shares of Zoetis by 251.9% during the third quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock valued at $121,000 after acquiring an additional 1,360 shares during the last quarter. Finally, Shine Investment Advisory Services Inc. increased its position in shares of Zoetis by 86.5% during the third quarter. Shine Investment Advisory Services Inc. now owns 2,242 shares of the company’s stock valued at $143,000 after acquiring an additional 1,040 shares during the last quarter. Hedge funds and other institutional investors own 93.19% of the company’s stock.

Zoetis Inc (NYSE ZTS) traded down $1.20 during midday trading on Thursday, hitting $73.91. 2,257,400 shares of the stock traded hands, compared to its average volume of 2,539,257. The company has a current ratio of 2.80, a quick ratio of 1.95 and a debt-to-equity ratio of 2.45. Zoetis Inc has a twelve month low of $52.00 and a twelve month high of $75.47. The stock has a market capitalization of $36,200.00, a price-to-earnings ratio of 38.90, a price-to-earnings-growth ratio of 1.91 and a beta of 1.06.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Thursday, November 2nd. The company reported $0.65 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.02. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.32 billion. During the same quarter last year, the firm posted $0.52 earnings per share. The business’s revenue for the quarter was up 8.5% compared to the same quarter last year. analysts forecast that Zoetis Inc will post 2.37 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 1st. Stockholders of record on Friday, January 19th will be paid a $0.126 dividend. This is a positive change from Zoetis’s previous quarterly dividend of $0.11. The ex-dividend date is Thursday, January 18th. This represents a $0.50 annualized dividend and a dividend yield of 0.68%. Zoetis’s dividend payout ratio (DPR) is presently 22.11%.

A number of equities research analysts have weighed in on ZTS shares. Morgan Stanley upgraded shares of Zoetis from an “equal weight” rating to an “overweight” rating and set a $80.00 price target for the company in a research report on Wednesday, November 29th. Jefferies Group reiterated a “buy” rating on shares of Zoetis in a research report on Friday, November 10th. Zacks Investment Research cut shares of Zoetis from a “buy” rating to a “hold” rating in a research report on Wednesday, November 1st. BidaskClub upgraded shares of Zoetis from a “sell” rating to a “hold” rating in a research report on Friday, October 13th. Finally, Cantor Fitzgerald set a $80.00 price target on shares of Zoetis and gave the company a “buy” rating in a research report on Tuesday, December 12th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $71.28.

TRADEMARK VIOLATION WARNING: “Zoetis Inc (ZTS) Position Cut by CGOV Asset Management” was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this article on another publication, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2018/01/11/zoetis-inc-zts-position-cut-by-cgov-asset-management.html.

Zoetis Company Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit